Today's Information

Provided by: All Cosmos Bio-Tech Holding Corporation
SEQ_NO 1 Date of announcement 2022/03/25 Time of announcement 15:24:54
Subject 
 ACBT REPORTS 2021FY Consolidated Financial
Results to the Board
Date of events 2022/03/25 To which item it meets paragraph 31
Statement 
1.Date of submission to the board of directors or approval by the board of
 directors:2022/03/25
2.Date of approval by the audit committee:2022/03/25
3.Start and end dates of financial reports or annual self-assessed financial
 information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):
2021/01/01~2021/12/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):2,197,323
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):594,365
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):273,241
7.Profit (loss) before tax accumulated from 1/1 to end of the period
 (thousand NTD):321,585
8.Profit (loss) accumulated from 1/1 to end of the period
 (thousand NTD):236,654
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):198,128
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):3.09
11.Total assets end of the period (thousand NTD):2,969,911
12.Total liabilities end of the period
(thousand NTD):591,278
13.Equity attributable to owners of parent end of the
period (thousand NTD):1,990,366
14.Any other matters that need to be specified:None.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

All Cosmos Bio-Tech Holding Corporation published this content on 25 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 March 2022 07:35:03 UTC.